Concepedia

Malcolm Weir

MW

Statistics

Publications

28

Citations

3.6K

H-Index

25

Active since

1984

Affiliations

Heptares Therapeutics (United Kingdom)(Current)

Imperial College London

GlaxoSmithKline (Germany)

University of Cambridge

Monash University

Malcolm Weir is an author at Heptares Therapeutics (United Kingdom) specializing in pharmacology, ligand binding, and biochemistry.

Publications per year

1984–2021

28

Publications

28

Structure of the Adenosine A2A Receptor in Complex with ZM241385 and the Xanthines XAC and Caffeine

A.S. Dore, N.J. Robertson, James C. Errey et al. · Structure · 2011 · 553 citations · Full text

Medicine, Molecular Biology, Pharmacology +13

Structure of class B GPCR corticotropin-releasing factor receptor 1

Kaspar Hollenstein, James Kean, Andrea Bortolato et al. · Nature · 2013 · 414 citations

Life Sciences, Biochemistry, Molecular Biology +10

Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain

A.S. Dore, Krzysztof Okrasa, Jayesh C. Patel et al. · Nature · 2014 · 411 citations

Life Sciences, Molecular Biology, Neuroscience +12

Discovery of 1,2,4-Triazine Derivatives as Adenosine A<sub>2A</sub> Antagonists using Structure Based Drug Design

Miles Congreve, Stephen P. Andrews, A.S. Dore et al. · Journal of Medicinal Chemistry · 2012 · 304 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Extra-helical binding site of a glucagon receptor antagonist

Ali Jazayeri, A.S. Dore, Daniel Lamb et al. · Nature · 2016 · 225 citations

Medicine, Biochemistry, Pharmacology +12

1–5 of 28